Stanford's Fatima Rodriguez Receives Prestigious 2025 Joseph A. Vita Award for Cardiovascular Research

Dr. Fatima Rodriguez's recognition with the Joseph A. Vita Award highlights significant advancements in personalized cardiovascular risk prediction and prevention strategies that address health disparities across diverse populations.

September 24, 2025
Stanford's Fatima Rodriguez Receives Prestigious 2025 Joseph A. Vita Award for Cardiovascular Research

Dr. Fatima Rodriguez, an associate professor of medicine and section chief of preventive cardiology at Stanford Medicine, will receive the 2025 Joseph A. Vita Award during the American Heart Association's Scientific Sessions 2025 in New Orleans. The award recognizes scientists whose research has significantly advanced cardiovascular biology or health within the past five years, with recipients selected by the editors-in-chief of the Association's 14 peer-reviewed scientific journals.

The Joseph A. Vita Award honors the legacy of Dr. Joseph A. Vita, the founding editor of the American Heart Association's open-access, peer-reviewed Journal of the American Heart Association (JAHA). Dr. Stacey E. Rosen, the American Heart Association's 2025-2026 volunteer president, emphasized that Dr. Rodriguez's work exemplifies the award's purpose through innovative, impactful, and patient-centered research that has directly improved cardiovascular risk assessment and prevention strategies.

Dr. Rodriguez's multidisciplinary research program leverages technology and data science to personalize cardiovascular risk prediction, uncover drivers of outcome disparities across populations, and develop evidence-based interventions. Her work represents a significant shift toward more personalized and data-driven approaches to cardiovascular disease prevention, particularly important given the persistent gaps in cardiovascular outcomes among different demographic groups. Her research receives funding from multiple prestigious organizations including the American Heart Association, the National Heart, Lung, and Blood Institute, and the Doris Duke Charitable Foundation.

The timing of this recognition underscores the growing importance of preventive cardiology as healthcare systems worldwide grapple with increasing rates of cardiovascular disease. Dr. Rodriguez's approach to using advanced data analytics and technology addresses critical needs in cardiovascular care by moving beyond one-size-fits-all prevention strategies toward more targeted interventions. Her research has practical implications for clinical practice, potentially influencing how healthcare providers assess risk and implement prevention measures for diverse patient populations.

Dr. Rodriguez expressed that personal family experiences with heart disease shaped her career focus on improving cardiovascular risk prediction and developing more equitable treatment strategies. With over 270 peer-reviewed publications and previous honors including the 2022 Douglas P. Zipes Distinguished Young Scientist Award from the American College of Cardiology, her work continues to influence the field of preventive cardiology. The award presentation during the opening session of the Scientific Sessions 2025, a premier global exchange of cardiovascular science advancements, positions her research at the forefront of international cardiovascular medicine discussions.